Cargando…

Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia

Dementia with Lewy Bodies (DLB) and Parkinson’s Disease Dementia (PDD) together, represent the second most common cause of dementia, after Alzheimer’s disease (AD). The synaptic dysfunctions underlying the cognitive decline and psychiatric symptoms observed throughout the development of PDD and DLB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vallortigara, Julie, Rangarajan, Sindhoo, Whitfield, David, Alghamdi, Amani, Howlett, David, Hortobágyi, Tibor, Johnson, Mary, Attems, Johannes, Ballard, Clive, Thomas, Alan, O’Brien, John, Aarsland, Dag, Francis, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000Research 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309165/ https://www.ncbi.nlm.nih.gov/pubmed/25671083 http://dx.doi.org/10.12688/f1000research.3786.1

Ejemplares similares

Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body Dementia
por: Alghamdi, Amani, et al.
Publicado: (2017)

Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias
por: Howlett, David R., et al.
Publicado: (2014)

Hospitalization in people with dementia with Lewy bodies: Frequency, duration, and cost implications
por: Mueller, Christoph, et al.
Publicado: (2017)

Structural synaptic signatures of Alzheimer's disease and dementia with Lewy bodies in the male brain
por: Glebov, Oleg O., et al.
Publicado: (2022)

Cognitive decline in dementia with Lewy bodies: a 5-year prospective cohort study
por: Rongve, A, et al.
Publicado: (2016)

Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers
por: Gibson, Lucy L., et al.
Publicado: (2023)

Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study
por: Stubendorff, Kajsa, et al.
Publicado: (2014)

Neuropathological characterization of Lemur tyrosine kinase 2 (LMTK2) in Alzheimer’s disease and neocortical Lewy body disease
por: Bencze, János, et al.
Publicado: (2019)

Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022
por: Abdelnour, Carla, et al.
Publicado: (2023)

((123)I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study
por: Siepel, Françoise J, et al.
Publicado: (2013)

Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical Correlates
por: Mulugeta, Ezra, et al.
Publicado: (2011)

Psychiatric and neuropsychiatric syndromes and COVID-19
por: Velayudhan, Latha, et al.
Publicado: (2020)

Mental health of people living with dementia in care homes during COVID-19 pandemic
por: Velayudhan, Latha, et al.
Publicado: (2020)

RENEWAL: REpurposing study to find NEW compounds with Activity for Lewy body dementia—an international Delphi consensus
por: O’Brien, John T., et al.
Publicado: (2022)

The neuropeptide landscape of human prefrontal cortex
por: Zhong, Wen, et al.
Publicado: (2022)

Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer’s disease but not Lewy body dementias
por: Chai, Yuek Ling, et al.
Publicado: (2023)

Increased phosphorylation of collapsin response mediator protein-2 at Thr514 correlates with β-amyloid burden and synaptic deficits in Lewy body dementias
por: Xing, Huayang, et al.
Publicado: (2016)

White Matter Hyperintensities in Mild Lewy Body Dementia
por: Oppedal, K., et al.
Publicado: (2012)

The Impact of Autonomic Dysfunction on Survival in Patients with Dementia with Lewy Bodies and Parkinson's Disease with Dementia
por: Stubendorff, Kajsa, et al.
Publicado: (2012)

Decreased DHA‐containing phospholipids in the neocortex of dementia with Lewy bodies are associated with soluble Aβ(42), phosphorylated α‐synuclein, and synaptopathology
por: Chong, Joyce R., et al.
Publicado: (2023)

A new visual rating scale for Ioflupane imaging in Lewy body disease
por: Lloyd, Jim J., et al.
Publicado: (2018)

Research criteria for the diagnosis of prodromal dementia with Lewy bodies
por: McKeith, Ian G., et al.
Publicado: (2020)

Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial
por: Husebo, Bettina S, et al.
Publicado: (2011)

Visual cortex in dementia with Lewy bodies: magnetic resonance imaging study
por: Taylor, John-Paul, et al.
Publicado: (2012)

Insights into Lewy body disease from rare neurometabolic disorders
por: Erskine, Daniel, et al.
Publicado: (2021)

Causal Evidence for the Dependence of the Magnitude Effect on Dorsolateral Prefrontal Cortex
por: Ballard, Ian C., et al.
Publicado: (2018)

Clinical and Neuropsychological Differences between Mild Parkinson's Disease Dementia and Dementia with Lewy Bodies
por: Petrova, Mariya, et al.
Publicado: (2015)

RAB39B is redistributed in dementia with Lewy bodies and is sequestered within aβ plaques and Lewy bodies
por: Koss, David J., et al.
Publicado: (2020)

Antipsychotic use in dementia: the relationship between neuropsychiatric symptom profiles and adverse outcomes
por: Mueller, Christoph, et al.
Publicado: (2020)

A Preliminary Comparison of the Methylome and Transcriptome from the Prefrontal Cortex Across Alzheimer’s Disease and Lewy Body Dementia
por: Fisher, Daniel W., et al.
Publicado: (2023)

The prefrontal cortex /
por: Fuster, Joaquin M.
Publicado: (2008)

Efficacy and Safety of Analgesic Treatment for Depression in People with Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM)
por: Erdal, Ane, et al.
Publicado: (2018)

Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort
por: Berge, Guro, et al.
Publicado: (2014)

Lemur Tyrosine Kinase 2 (LMTK2) Level Inversely Correlates with Phospho-Tau in Neuropathological Stages of Alzheimer’s Disease
por: Bencze, János, et al.
Publicado: (2020)

Changes to the lateral geniculate nucleus in Alzheimer's disease but not dementia with Lewy bodies
por: Erskine, Daniel, et al.
Publicado: (2015)

Implicit threat learning involves the dorsolateral prefrontal cortex and the cerebellum
por: Lam, Charlene L.M., et al.
Publicado: (2023)

Exome sequencing in dementia with Lewy bodies
por: Keogh, M J, et al.
Publicado: (2016)

Neurodegenerative Disease Associated Pathways in the Brains of Triple Transgenic Alzheimer’s Model Mice Are Reversed Following Two Weeks of Peripheral Administration of Fasudil
por: Killick, Richard, et al.
Publicado: (2023)

Neuropsychology of prefrontal cortex
por: Siddiqui, Shazia Veqar, et al.
Publicado: (2008)

Development of prefrontal cortex
por: Kolk, Sharon M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1t6j1ienui0fg1h7mrefg61uiu